In this issue:
Higher effectiveness but greater toxicity with axi-cel vs tisa-cel for RR DLBCL
Survival advantage with first-line consolidation transplant vs WBRT in PCNSL
Positive outcomes reported for adult patients with IEI after alloSCT
HLA-matched sibling donor preferrable for alloSCT in patients with MDS
Significant long-term health burden in survivors of AML treated with transplant
Younger adult survivors of SCT have worse mental health and cancer-related distress
Unrelated uDCBT vs haploidentical peripheral blood SCT for AML
Time-dependent prediction of mortality and CMV reactivation after alloSCT
Please login below to download this issue (PDF)